Skip to content

Clinical trials

Completed Phase 1/2 Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 1/2 Status: Completed Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20072
20093
20111
20121
20131
20163
20174
20182
20193
20201
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vaccinex Inc.2
AVEO Pharmaceuticals, Inc.1
BeiGene1
CRISPR Therapeutics AG1
Eisai Co., Ltd.1
Eli Lilly and Company1
Federation Francophone de Cancerologie Digestive1
Genelux Corporation1
Genocea Biosciences, Inc.1
HiberCell, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma26
Neoplasms12
Carcinoma, Non-Small-Cell Lung7
Head and Neck Neoplasms5
Breast Neoplasms4
Carcinoma, Hepatocellular4
Carcinoma, Squamous Cell4
Lung Neoplasms4
Pancreatic Neoplasms4
Squamous Cell Carcinoma of Head and Neck4

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.